Article
The APOM polymorphism as a novel risk factor for dyslipidaemia in rheumatoid arthritis: a possible shared link between disease susceptibility and dyslipidaemia.
Clinical and experimental rheumatology - 1 Jan 2000
Park Yune-Jung, Yoo Seung-Ah, Lee Jeong-Hwa, Chung Yeun-Jun, Cho Chul-Soo, Kim Wan -Uk
Abstract excerpt
OBJECTIVES: A decrease in high-density lipoprotein (HDL) cholesterol during inflammation is common in many rheumatologic diseases, including rheumatoid arthritis (RA). Apolipoprotein M (apoM) is an apolipoprotein predominantly associated with HDL cholesterol. Recently, apoM polymorphisms have been related with RA susceptibility. We investigated the possible association between an APOM polymorphism and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
